Oramed Pharmaceuticals (ORMP) Other Non-Current Liabilities (2011 - 2024)
Oramed Pharmaceuticals (ORMP) recorded Other Non-Current Liabilities of $60,000 in Q4 2024, down 4.8% from $63,000 a year earlier and unchanged from the prior quarter.
Oramed Pharmaceuticals (ORMP) Other Non-Current Liabilities (2011 - 2024) Analysis & Trends
Starting with Q4 2011, Oramed Pharmaceuticals' Other Non-Current Liabilities history includes 51 quarters.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of -44.6% (FY2019 to FY2024).
- Across earlier years, Other Non-Current Liabilities came in at $63,000 in FY2023 (+3.3%), $61,000 in FY2022 (-38.4%), $99,000 in FY2021 and $1.03 million in FY2020 (-9.9%).
- Quarterly Other Non-Current Liabilities has ranged from $59,000 in Q1 2023 to $1.03 million in Q4 2020 over the past five years.
- On a year-over-year basis, Other Non-Current Liabilities has declined for three consecutive quarters, with an average decline of 4.5% over the last eight quarters.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 10.0% in Q2 2023, against a decline of 88.0% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $60,000 (Q3 2024), $60,000 (Q2 2024) and $63,000 (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Oramed Pharmaceuticals | 164.02 Mn | -170.72 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 60,000.00 |
| Sep 30, 2024 | 60,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Mar 31, 2024 | 63,000.00 |
| Dec 31, 2023 | 74,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | 66,000.00 |
| Mar 31, 2023 | 59,000.00 |
| Dec 31, 2022 | 61,000.00 |
| Sep 30, 2022 | 61,000.00 |
| Jun 30, 2022 | 60,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Nov 30, 2021 | 122,000.00 |
| Aug 31, 2021 | 124,000.00 |
| May 31, 2021 | 171,000.00 |
| Feb 28, 2021 | 188,000.00 |
| Nov 30, 2020 | 223,000.00 |
| Aug 31, 2020 | 1.24 Mn |
| May 31, 2020 | 205,000.00 |
| Feb 29, 2020 | 243,000.00 |
Oramed Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ORMP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ORMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ORMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();